针对癌症中核代谢调节的潜在疗法
Yanjie Chen1, Jie Xu1, Xiaoyi Liu1
1Department of Obstetrics and Gynecology The Third Affiliated Hospital of Chongqing Medical University Chongqing China.
MedComm
|November 30, 2023
概括
癌细胞利用涉及代谢物和酶的核代谢信号来驱动增殖和基因转录. 针对这种代谢-基因组轴为癌症治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢研究研究 代谢研究
背景情况:
- 遗传变化和代谢失调是癌症发病的关键驱动因素.
- 代谢物和酶越来越多地被发现转移到核中,影响瘤细胞的增殖.
- 了解核代谢信号在癌症中的作用仍然不完整.
研究的目的:
- 审查核代谢信号的监管格局.
- 阐明核代谢产物和酶在癌症中的作用.
- 在代谢-基因组转录轴内识别潜在的治疗点.
主要方法:
- 关于癌症中核代谢信号的综合文献综述.
- 探索将代谢流与核过程联系起来的分子机制.
- 对表观遗传调制,DNA修复和基因表达的影响的分析.
主要成果:
- 核代谢信号显著影响表观遗传调制,DNA损伤修复和基因表达调节.
- 细胞核内的代谢酶和代谢物在瘤进展中起着关键作用.
- 核代谢和基因组之间的相互作用对癌细胞增殖至关重要.
结论:
- 核代谢信号传递是癌症生物学的一个关键方面.
- 新兴发现强调了代谢-基因组转录轴作为一种新的治疗点.
- 准核代谢途径为癌症治疗提供了创新的治疗范式.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Electron Transport Chain: Complex I and II
14.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.0K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


